The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - Results of an international collaborative study

Familial Cancer

Volumn 1, Issue 2, 2001, Pages 87-92

  Müller, Wolfram ^a   Burgart, Lawrence J ^b   Krause Paulus, Ruth ^a   Thibodeau, Stephen N ^b   Almeida, M ^c   Edmonston, T Brocker ^d   Boland, C R ^e   Sutter, C ^f   Jass, J R ^g   Lindblom, A ^h   Lubinski, J ⁱ   Macdermot, K ^j   Sanders, D S A ^k   Morreau, H ^l   Muller A ^m   Oliani, C ⁿ   Orntoft, T ^o   De Leon, M Ponz ^p   Rosty, C ^q   Rodriguez Bigas, M ^r   Ruschoff J ^s   Ruszkiewicz, A ^t   Sabourin, J ^u   Salovaara, R ^v   Möslein, Gabriela ^a   more..

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MAYO CLINIC   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ POMERANIAN MEDICAL UNIVERSITY   (Poland)

^j ROYAL FREE HOSPITAL   (United Kingdom)

^k Medical School   (United Kingdom)

^l LEIDEN UNIVERSITY   (Netherlands)

^m UNIVERSITY OF GÖTTINGEN   (Germany)

ⁿ UNIVERSITY HOSPITAL OF VERONA   (Italy)

^o AARHUS UNIVERSITY   (Denmark)

^p UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^q UNIVERSITÉ PARIS DESCARTES   (France)

^r ROSWELL PARK CANCER INSTITUTE   (United States)

^s KLINIKUM KASSEL   (Germany)

^t INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^u INSTITUT GUSTAVE ROUSSY   (France)

^v UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

HMLH1; HMSH2; HNPCC; Immunohistochemistry; Mismatch repair

Indexed keywords

ANALYTIC METHOD; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER SCREENING; COLORECTAL CANCER; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MISMATCH REPAIR; MULTIGENE FAMILY; PRIORITY JOURNAL; RELIABILITY; TISSUE FIXATION; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; BASE PAIR MISMATCH; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; DNA REPAIR; GENETIC SCREENING; HUMANS; IMMUNOENZYME TECHNIQUES; INTERNATIONAL COOPERATION; LABORATORIES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OBSERVER VARIATION; PEDIGREE; REPRODUCIBILITY OF RESULTS;

EID: 6444245757     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013840907881     Document Type: Article

References (30)

1. Hamilton SR. The molecular genetics of colorectal neoplasia. Gastroenterology 1993; 105: 3-7.
2. Potter J.D. Colorectal cancer: Molecules and populations. J Natl Cancer Inst 1999; 91: 916-32.
3. Dietmaier W, Wallinger S, Bocker T et al. Diagnostic microsatellite instability: Definition and correlation with mismatch repair expression. Cancer Res 1997; 57: 4749-56.
4. Thibodeau SN, French AJ, Roche PC et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56: 4836-40.
5. Ponz de Leon M. Descriptive epidemiology of hereditary non-polyposis colorectal cancer. Tumori 1996; 82: 102-106.
6. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 1758-62.
7. Aaltonen LA, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
8. Watson P, Lynch HT. Extracolonic cancer in hereditary non-polyposis colorectal cancer. Cancer 1993; 71: 677-85.
9. Vasen HFA, Wijnen JT, Menko FH et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996; 110: 1020-7.
10. Vasen HFA, Sanders EA, Taal BG et al. The risk of brain tumors in hereditary nonpolyposis colorectal cancer (HNPCC). Int J Cancer 1996; 65: 422-5.
11. Sijmons RH, Kiemeny LA, Witjes JA, Vasen HF. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: Risks and screening options. J Urol 1998; 160: 466-70.
12. Aarnio M, Mecklin JP, Aaltonen LA et al. Life-time risk of different cancers in hereditary nonpolyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64: 430-3.
13. Myrhoj T, Bisgaard ML, Bernstein I et al. Hereditary non-polyposis colorectal cancer: Clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997; 32: 572-6.
14. Levin B. Why hereditary nonpolyposis colorectal carcinoma patients appear to have better survival than patients with sporadic colorectal carcinoma [editorial; comment]. Cancer 1998; 83: 201-3.
15. Cawkwell L, Gray S, Murgatroyd H et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999; 45: 409-15.
16. Claij N, te Riele H. Microsatellite instability in human cancer: A prognostic marker for chemotherapy? Exp Cell Res 1999; 246: 1-10.
17. Peltomaki P, Vasen HFA. The International Collaborative Group on HNPCC. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. Gastroenterology 1997; 113: 1146-58.
18. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57.
19. Honchel R, Halling KC, Thibodeau SN. Genomic instability in neoplasia. Cell Biol 1995; 6: 45-52.
20. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-9.
21. Wijnen J, Vasen HFA, Meera Khan P et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339: 511-8.
22. Kane MF, Loda M, Gaida GM et al. Methylation of the hMLH1 promotor correlates with lack of expression of the hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997; 57: 808-11.
23. Herman JG, Umar A, Polyak K et al. Incidence and functional consequence of hMLH1 promotor hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95: 6870-5.
24. Veigl ML, Kasturi L, Olechnowicz J et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998; 95: 8698-702.
25. Cunningham JM, Christensen ER, Tester DJ et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 1998; 58: 3455-60.
26. Thibodeau SN, French AJ, Cunningham JM et al. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principle involvement of hMLH1. Cancer Res 1998; 58: 1713-8.
27. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT. The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-5.
28. Liu B, Farrington SM, Petersen GM et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995; 1: 348-52.
29. Rodriguez-Bigas MA, Vasen HFA, Pekka-Mecklin J et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg 1997; 225: 202-7.
30. Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? [editorial] Dis Colon Rectum 1996; 39: 109-10.